224
Do Doctors Prescribe Antibiotics Out of Fear of Malpractice?
One candidate explanation for the excessive use of antibiotics in the U.S. compared to other developed countries is the medical malpractice system. Doctors in the U.S. face considerable legal pressure: more than 7% of all doctors are sued every given year, and the lifetime risk of being sued is north of 75% (Jena et al. 2011). In response to liability pressure, doctors have been found to practice defensive medicine, i.e., to administer diagnostic tests, treatments, or medications with expected benefits below cost to protect themselves against legal proceedings (Kessler and McClellan 1996). The frequent use of antibiotics may constitute a form of defensive medicine: doctors may feel inclined to prescribe an antibiotic against their own clinical judgement because the antibiotic presents a safeguard against serious bacterial infections, which may trigger a malpractice claim if left untreated. Anecdotal evidence and physician surveys support this theory. For instance, of the 824 physicians who participated in a survey in Pennsylvania, 33% reported to prescribe more medications than medically indicated in response to liability pressure (Studdert et al. 2005). However, to date, no attempt has been made to examine the influence of liability pressure on antibiotic prescribing in actual clinical decisions.
This paper is the first to systematically examine the relationship between liability pressure and antibiotic prescriptions. Using a simple theoretical model of physician prescribing behavior, I link the effect that a tort reform has on the number of antibiotics prescribed with the clinical appropriateness of these prescriptions. The model can be used to test for whether antibiotics constitute a form of defensive medicine.
Using 20 years of data from the National Ambulatory Care Survey (NAMCS), a nationally representative sample of visits to office-based physicians in the U.S., I estimate the causal effect of liability pressure on antibiotic prescription rates with a difference-in-differences model that exploits the variation in tort law reforms across U.S. states. I allow for heterogenous responses to the malpractice environment across doctors and patients, for example based on the patient’s type of health insurance. Throughout the analysis, I carefully consider the possibility of legislative endogeneity.